Aberrant activation of the Nrf2 pathway in head and neck squamous cell carcinoma (HNSCC) confers resistance to oxidative damage and ferroptosis, particularly in tumors exhibiting mesenchymal features or enhanced EMT [5,53]. The gene discussed is NFE2L2; the disease is head and neck squamous cell carcinoma.